journal article·2024-05

MXene Boosted Ultrasensitive Electrochemical Detection of 5‐Hydroxymethylcytosine in Genomic DNA from Complex Backgrounds

Zhenzhen Xu, Zhigang Wang, Dingmeng Hu, Huiqin Chen, Yufei Yan, Yuan Li, Mengjing Tu, Qiaofeng Shen, Xuanyi Liu, Rui Li, Cheng Lu, Fei Xue, Congying Xie, Gen Yang

Advanced Functional Materials· Volume 34· Issue 19
Publisher page

Abstract

Abstract 5‐Hydroxymethylcytosine in genomic DNA (5hmC‐DNA), a predominant epigenetic mark, plays key roles in a broad range of bioprocesses such as cancer progression. However, efficient detection of 5hmC‐DNA, especially from highly complex biological specimens, remains a harsh challenge due to its low abundance as well as the serious disturbance of non‐targets. Leveraging MXene as the signal booster, an electrochemical biosensing technique is presented here for ultrasensitive detection of 5hmC‐DNA from complex biological samples. The developed technique integrates enzyme‐catalyzed transform of the hydroxyl group of 5hmC, sequence‐specific recognition of the 5hmC‐DNA targets, and facile electrochemical reaction. Remarkably, nanosized Ti3C2Tx MXene is introduced as a highly conductive agent, managing to greatly boost the signals. Exhibiting outstanding consistency and robustness, the technique not only achieves excellent linear responses in a broad range of 5hmC‐DNA (1.0 × 10−13–1.0 × 10−9 m) with the lowest detection limit of 59 fM but also possesses excellent selectivity against 5hmC analogs of including cytosine (C)‐ and 5‐methylcytosine (5mC). More importantly, a proof‐of‐concept validation demonstrates the extraordinary ability of this technique for directly detecting 5hmC‐DNA from complex backgrounds including cellular genomic extracts and serum of irradiated or non‐irradiated mice, suggesting its highly promising potential for diverse applications such as early cancer screening.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Advanced biosensing and bioanalysis techniques · MXene and MAX Phase Materials · Epigenetics and DNA Methylation

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Wenzhou Institute University of Chinese Academy of Sciences Wenzhou 325000 P. R. China

Oncology Discipline Group Department of the Second Affiliated Hospital of Wenzhou Medical University Wenzhou 325024 P. R. China

School of Pharmaceutical Sciences Wenzhou Medical University Wenzhou 325035 P. R. China

School of Biomedical Engineering School of Ophthalmology and Optometry and Eye Hospital Wenzhou Medical University Wenzhou 325001 P. R. China

School of Public Health and Management Wenzhou Medical University Wenzhou 325035 P. R. China

Postgraduate Training Base Alliance of Wenzhou Medical University Wenzhou 325035 P. R. China

Medical and Radiation Oncology Department of the Second Affiliated Hospital of Wenzhou Medical University Wenzhou 325024 P. R. China

State Key Laboratory of Nuclear Physics and Technology School of Physics Peking University Beijing 100871 P. R. China

Funding

National Key Research and Development Program of China · National Natural Science Foundation of China

References (49)

Show source-provided references
1. 10.1038/nbt.173210.1038/nbt.1732 ↗
2. 10.1126/science.117011610.1126/science.1170116 ↗
3. 10.1038/cr.2015.15010.1038/cr.2015.150 ↗
4. 10.1038/cr.2017.12110.1038/cr.2017.121 ↗
5. 10.1136/gutjnl-2019-31888210.1136/gutjnl-2019-318882 ↗
6. 10.1016/j.cell.2012.07.03310.1016/j.cell.2012.07.033 ↗
7. 10.1016/j.ygeno.2014.08.01710.1016/j.ygeno.2014.08.017 ↗
8. 10.1007/s00441-014-1797-910.1007/s00441-014-1797-9 ↗
9. 10.1038/s41467-021-24425-w10.1038/s41467-021-24425-w ↗
10. 10.3389/fonc.2016.0015510.3389/fonc.2016.00155 ↗
11. 10.1021/acs.analchem.6b0023010.1021/acs.analchem.6b00230 ↗
12. 10.3389/fgene.2017.0010010.3389/fgene.2017.00100 ↗
13. 10.1038/nsmb.307110.1038/nsmb.3071 ↗
14. 10.1126/science.122067110.1126/science.1220671 ↗
15. 10.1016/j.cell.2012.04.02710.1016/j.cell.2012.04.027 ↗
16. 10.1038/s41587-019-0041-210.1038/s41587-019-0041-2 ↗
17. 10.1038/nmeth.177910.1038/nmeth.1779 ↗
18. 10.1038/nature0930310.1038/nature09303 ↗
19. 10.1021/ac503889510.1021/ac5038895 ↗
20. 10.1016/j.bios.2016.12.03910.1016/j.bios.2016.12.039 ↗
21. 10.1021/ac402067610.1021/ac4020676 ↗
22. 10.1038/nature1000810.1038/nature10008 ↗
23. 10.1016/j.snb.2019.05.02810.1016/j.snb.2019.05.028 ↗
24. 10.1016/j.bios.2017.08.02310.1016/j.bios.2017.08.023 ↗
25. 10.1016/j.bios.2019.11190810.1016/j.bios.2019.111908 ↗
26. 10.1016/j.bios.2018.11.05410.1016/j.bios.2018.11.054 ↗
27. 10.1016/j.cej.2018.09.13810.1016/j.cej.2018.09.138 ↗
28. 10.1021/acs.analchem.8b0466310.1021/acs.analchem.8b04663 ↗
29. 10.1016/j.jallcom.2023.16971510.1016/j.jallcom.2023.169715 ↗
30. 10.1021/acs.analchem.1c0338910.1021/acs.analchem.1c03389 ↗
31. 10.1016/j.cej.2020.12496610.1016/j.cej.2020.124966 ↗
32. 10.3390/nano1104098510.3390/nano11040985 ↗
33. 10.1002/adhm.20210119310.1002/adhm.202101193 ↗
34. 10.3390/cancers1315378710.3390/cancers13153787 ↗
35. 10.1016/j.talanta.2017.04.05110.1016/j.talanta.2017.04.051 ↗
36. 10.1016/j.talanta.2019.12059710.1016/j.talanta.2019.120597 ↗
37. 10.1016/j.talanta.2022.12342110.1016/j.talanta.2022.123421 ↗
38. 10.1002/adfm.20160035710.1002/adfm.201600357 ↗
39. 10.1016/j.bios.2021.11394310.1016/j.bios.2021.113943 ↗
40. 10.1002/adfm.20190960310.1002/adfm.201909603 ↗
41. 10.1126/science.abf158110.1126/science.abf1581 ↗
42. Hu C. · Adv. Funct. Mater. · 2023 · 33 · 37
43. 10.1016/j.physrep.2019.12.00610.1016/j.physrep.2019.12.006 ↗
44. 10.1016/j.bios.2018.02.02110.1016/j.bios.2018.02.021 ↗
45. 10.1021/acsnano.6b0524010.1021/acsnano.6b05240 ↗
46. Liu J. · Adv. Funct. Mater. · 2018 · 29 · 6
47. 10.1002/adfm.20210526410.1002/adfm.202105264 ↗
48. 10.1002/adfm.20221338210.1002/adfm.202213382 ↗
49. 10.1016/j.bios.2019.11153110.1016/j.bios.2019.111531 ↗